Meadow Creek Investment Management LLC grew its stake in Hospital Co. of America (NYSE:HCA) by 56.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,828 shares of the company’s stock after acquiring an additional 16,212 shares during the quarter. Meadow Creek Investment Management LLC’s holdings in Hospital Co. of America were worth $3,937,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of HCA. Parallel Advisors LLC lifted its position in shares of Hospital Co. of America by 76.2% in the fourth quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock valued at $117,000 after acquiring an additional 578 shares in the last quarter. Bronfman E.L. Rothschild L.P. lifted its position in shares of Hospital Co. of America by 108.0% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock valued at $213,000 after acquiring an additional 1,259 shares in the last quarter. Kovack Advisors Inc. purchased a new position in Hospital Co. of America during the fourth quarter worth about $234,000. Financial Counselors Inc. purchased a new position in Hospital Co. of America during the fourth quarter worth about $243,000. Finally, Focused Wealth Management Inc purchased a new position in Hospital Co. of America during the fourth quarter worth about $257,000. Institutional investors and hedge funds own 73.48% of the company’s stock.
NYSE:HCA traded down $2.00 on Friday, hitting $96.24. 1,965,749 shares of the stock were exchanged, compared to its average volume of 1,972,472. The firm has a market capitalization of $34,374.54, a PE ratio of 14.60, a P/E/G ratio of 0.98 and a beta of 0.47. The company has a debt-to-equity ratio of -6.58, a current ratio of 1.62 and a quick ratio of 1.36. Hospital Co. of America has a fifty-two week low of $71.18 and a fifty-two week high of $106.84.
Hospital Co. of America (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.87 by $0.25. Hospital Co. of America had a negative return on equity of 49.49% and a net margin of 4.89%. The company had revenue of $11.56 billion during the quarter, compared to analyst estimates of $11.19 billion. During the same period in the prior year, the firm posted $1.80 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis. research analysts anticipate that Hospital Co. of America will post 8.71 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, March 30th. Stockholders of record on Thursday, March 1st were paid a $0.35 dividend. The ex-dividend date of this dividend was Wednesday, February 28th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.45%. Hospital Co. of America’s dividend payout ratio (DPR) is currently 21.24%.
In related news, major shareholder Thomas F. Frist, Jr. bought 28,650 shares of the stock in a transaction dated Tuesday, February 20th. The stock was acquired at an average price of $101.07 per share, for a total transaction of $2,895,655.50. Following the completion of the purchase, the insider now owns 389,855 shares in the company, valued at $39,402,644.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Charles J. Hall sold 49,882 shares of the stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $101.29, for a total value of $5,052,547.78. Following the completion of the sale, the insider now owns 62,048 shares of the company’s stock, valued at approximately $6,284,841.92. The disclosure for this sale can be found here. In the last quarter, insiders sold 479,918 shares of company stock valued at $48,186,093. Insiders own 2.80% of the company’s stock.
Several research firms recently weighed in on HCA. Cantor Fitzgerald reiterated a “buy” rating and set a $115.00 target price on shares of Hospital Co. of America in a research report on Tuesday, January 30th. BMO Capital Markets increased their target price on Hospital Co. of America from $96.00 to $115.00 and gave the stock an “outperform” rating in a research report on Thursday, February 1st. They noted that the move was a valuation call. Morgan Stanley increased their target price on Hospital Co. of America from $84.00 to $91.00 and gave the stock an “underweight” rating in a research report on Thursday, February 1st. Sanford C. Bernstein reiterated a “market perform” rating and set a $116.00 target price (up from $105.00) on shares of Hospital Co. of America in a research report on Thursday, February 1st. Finally, Leerink Swann increased their target price on Hospital Co. of America from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $106.21.
ILLEGAL ACTIVITY WARNING: This news story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/08/meadow-creek-investment-management-llc-purchases-16212-shares-of-hca-healthcare-inc-hca.html.
Hospital Co. of America Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Receive News & Ratings for Hospital Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hospital Co. of America and related companies with MarketBeat.com's FREE daily email newsletter.